Abiopharma

🔍 Warman Nanuk (Executive)

Company: CitroTech Inc. (CITR)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Acquired 177,794 shares of Common (Direct)
  Date: 2026-04-16 | Code: C | equity_swap_involved: 0 | shares_owned_after: 177,794.00 | transaction_form_type: 4
• Sold 177,794 shares of Series C Convertible Preferred Stock (Derivative)
  Date: 2026-04-16 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each share of Series C Convertible Preferred Stock is convertible at any time at the option of the holder into 3.3333 shares of Common Stock. The Series C Convertible Preferred Stock has no expiration date.